• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Characteristics and Outcomes of Young Children Hospitalized With Laboratory-confirmed Influenza or Respiratory Syncytial Virus in Ontario, Canada, 200

tetano

Editor, Senior Moderator
Pediatr Infect Dis J. 2019 Apr;38(4):362-369. doi: 10.1097/INF.0000000000002164.
[h=1]Characteristics and Outcomes of Young Children Hospitalized With Laboratory-confirmed Influenza or Respiratory Syncytial Virus in Ontario, Canada, 2009-2014.[/h] Buchan SA[SUP]1,[/SUP][SUP]2[/SUP], Chung H[SUP]3[/SUP], Karnauchow T[SUP]4,[/SUP][SUP]5[/SUP], McNally JD[SUP]4[/SUP], Campitelli MA[SUP]3[/SUP], Gubbay JB[SUP]2,[/SUP][SUP]6,[/SUP][SUP]7[/SUP], Katz K[SUP]6,[/SUP][SUP]8[/SUP], McGeer AJ[SUP]1,[/SUP][SUP]6,[/SUP][SUP]9[/SUP], Richardson DC[SUP]10[/SUP], Richardson SE[SUP]6,[/SUP][SUP]7[/SUP], Simor A[SUP]6,[/SUP][SUP]11[/SUP], Smieja M[SUP]12[/SUP], Zahariadis G[SUP]13,[/SUP][SUP]14[/SUP], Tran D[SUP]7,[/SUP][SUP]15[/SUP], Crowcroft NS[SUP]1,[/SUP][SUP]2,[/SUP][SUP]6[/SUP], Rosella LC[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3[/SUP], Kwong JC[SUP]1,[/SUP][SUP]2,[/SUP][SUP]3,[/SUP][SUP]16,[/SUP][SUP]17[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Respiratory illnesses are a major contributor to pediatric hospitalizations, with influenza and respiratory syncytial virus (RSV) causing substantial morbidity and cost each season. We compared the characteristics and outcomes of children 0-59 months of age who were hospitalized with laboratory-confirmed influenza or RSV between 2009 and 2014 in Ontario, Canada.
[h=4]METHODS:[/h] We included hospitalized children who were tested for influenza A, influenza B and RSV and were positive for a single virus. We characterized individuals by their demographics and healthcare utilization patterns and compared their hospital outcomes, in-hospital cost and postdischarge healthcare use by virus type and by presence of underlying comorbidities.
[h=4]RESULTS:[/h] We identified and analyzed 7659 hospitalizations during which a specimen tested positive for influenza or RSV. Children with RSV were the youngest whereas children with influenza B were the oldest [median ages 6 months (interquartile range: 2-17 months) and 25 months (interquartile range: 10-45 months), respectively]. Complex chronic conditions were more prevalent among children with all influenza (sub)types than RSV (31%-34% versus 20%). In-hospital outcomes were similar by virus type, but in children with comorbidities, postdischarge outcomes varied. We observed no differences in in-hospital cost between viruses or by presence of comorbidities [overall median cost: $4150 Canadian dollars (interquartile range: $3710-$4948)].
[h=4]CONCLUSIONS:[/h] Influenza and RSV account for large numbers of pediatric hospitalizations. RSV and influenza were similar in terms of severity and cost in hospitalized children. Influenza vaccination should be promoted in pregnant women and young children, and a vaccine against RSV would mitigate the high burden of RSV.


PMID: 30882725 DOI: 10.1097/INF.0000000000002164







[TABLE="cellspacing: 1"]
[TR]
[TD="class: SL, width: 10%, align: right"][/TD]
[TD="class: SL, width: 20%, align: left"]Detect languageundefined[/TD]
[TD="class: SL, width: 3, align: center"]
[/TD]
[TD="class: SL, width: 20%, align: left"]undefined[/TD]
[TD="class: SL, width: 8%, align: center"]
[/TD]
[TD="class: SL, width: 8%, align: center"]
[/TD]
[TD="class: SL, width: 8%, align: center"]

[/TD]
[TD="class: SL, width: 8%, align: center"]
[/TD]
[TD="class: SL, width: 15%, align: right"]
[/TD]
[/TR]
[/TABLE]





Text-to-speech function is limited to 200 characters


[TD="class: SL, width: 5%, align: center"][/TD]
[TD="class: SL, width: 5%, align: left"]
[/TD]
[TD="class: SL, width: 70%, align: center"] Options : History : Feedback : Donate [/TD]
[TD="class: SL, width: 15%, align: right"]Close[/TD]
 
Back
Top Bottom